Live Breaking News & Updates on Philogen Announces First Quarter

Stay updated with breaking news from Philogen announces first quarter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Philogen Announcements | Philogen: Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

Investegate announcements from Philogen, Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress ....

United States , Rosia Siena , Dario Neri , World Melanoma Congress , Christian Lizak Business Development , Italian Stock Exchange , Drug Administration , European Medicinal Agency , Proceedings Of The National Academy Sciences , European Medicines Agency , University Of Maastricht , Italian Stock Exchange On , Philogen Announces First Quarter , Provides Update , Announces First Quarter , Soft Tissue Sarcoma , Globe Newswire , Initial Public Offering , Chief Executive Officer , Chief Scientific Officer , Data Safety Monitoring Board , Recurrence Free Survival , American Phase , Soft Tissue , Grade Glioma , Science Translational Medicine ,

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress

Philogen Announces First Quarter 2021 Results and Provides Update on Pipeline Progress
May 12, 2021
on track for
Phase III European trial in stage IIIB/C melanoma. Opening of additional clinical centers to boost recruitment rate is ongoing.
E
Fibromun
Philogen is well capitalized,
about
th
the
here (https://us06web.zoom.us/webinar/register/WN nEuoFxsHTXSTdtS4RBslYg)
Siena (Italy), 12 May 2021 - (Globe Newswire) - Philogen S.p.A. (BIT:PHIL) - a listed clinical-stage biotechnology company focused on the development of innovative medicines based on tumor targeting antibodies and small molecule ligands, is pleased to announce progress updates for its fully-owned immunocytokine and small molecule programs. ....

United States , Melissa Gardiner , Mary Jane Elliott , Davide Salvi , Rosia Siena , Dario Neri , World Melanoma Congress , Christian Lizak Business Development , Italian Stock Exchange , Drug Administration , European Medicinal Agency , Proceedings Of The National Academy Sciences , European Medicines Agency , University Of Maastricht , Consilium Strategic Communications , Italian Stock Exchange On , Philogen Announces First Quarter , Provides Update , Soft Tissue Sarcoma , Globe Newswire , Initial Public Offering , Chief Executive Officer , Chief Scientific Officer , Data Safety Monitoring Board , Recurrence Free Survival , American Phase ,